10 Aug 2021 | 02:45 PM GMT
Past Meeting

Masterclass: DTx Reimbursement in the US

Participants:

Armin Furtwaengler Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbHOther
Other
Armin Furtwaengler
Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbH
Chris Wasden Chief Strategy OfficerTwillOther
Other
Chris Wasden
Chief Strategy OfficerTwill
Cyndi Williams SVP Strategic OperationsDojo
Cyndi Williams
SVP Strategic OperationsDojo
Emily Lewis Global Digital Transformation LeadUCB
Emily Lewis
Global Digital Transformation LeadUCB
Jaydev Thakkar Chief Operations OfficerBiofourmisOther
Other
Jaydev Thakkar
Chief Operations OfficerBiofourmis
JC
Jennifer Cook Team Lead, Global Market Access Respiratory Boehringer IngelheimOther
JC
Other
Jennifer Cook
Team Lead, Global Market Access Respiratory Boehringer Ingelheim
Jim Howard CEOReadout HealthOther
Other
Jim Howard
CEOReadout Health
Joseph Rubinsztain CEOChronWell
Joseph Rubinsztain
CEOChronWell
LV
Lauren van den Heuvel Associate director, innovative solutionsOtsuka Pharmaceutical
LV
Lauren van den Heuvel
Associate director, innovative solutionsOtsuka Pharmaceutical
Mike Pace Founder & CEOPalmHealthCoProfessional Services
Professional Services
Mike Pace
Founder & CEOPalmHealthCo
Rick Bartels President/Founder DTxCCHealth Tech & Solutions
Health Tech & Solutions
Rick Bartels
President/Founder DTxCC
Stanton Sugarman Lead Commercial OperationsGAIA AGLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Stanton Sugarman
Lead Commercial OperationsGAIA AG
Vasyl Pyrozhyk Vice PresidentSMBCOther
Other
Vasyl Pyrozhyk
Vice PresidentSMBC

About this Meeting

Even though showing evidence and getting regulatory approval are important to build successful DTx tools, getting paid for these is crucial in order to thrive. While there are some commercialization models that might work, like D2C or partnerships with pharma, getting reimbursed by public and private payers will be critical to reach the levels of adoption needed for higher revenues from DTx products. Join us in this US-focused interactive masterclass led by Happify Health where we will talk about: 

  •  What are the drivers for payers to reimburse DTx products/services? Any differences in requirements between CMS & private payers? 
  •  Payers’ requirements and best practices to meet their expectations. 
  •  Role of Pharmacy Benefit Managers (PBMs) as an entry point for DTx reimbursement - is being included in their formularies enough?
  •  Role of CPT and HCPCS codes: paying physicians for their use of DTx in the practice of medicine.

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.